Literature DB >> 16194767

Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders.

L Kempf1, N Hussain, J B Potash.   

Abstract

Psychiatry has long struggled with the problem of how to understand the relationship between psychotic symptoms and mood symptoms. In the past, these debates were over conceptualizations of categories based on syndromal definitions of mental illnesses. Ample data now exists that provide insight into the biologic basis for syndromal distinctions. We examine the syndromes of mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features, reviewing their classification, clinical features, course, and treatment. We provide evidence that, clinically, mood disorders and schizophrenia do not separate neatly. We will also review data arising from studies in brain imaging, molecular neurobiology, and genetics. Evidence is accumulating that overlap across diagnostic boundaries for both pathologic and etiologic factors exist, along with disorder-specific factors. The nosology that will carve the reality of psychotic illness at the joints awaits further advances in genetics and neurobiology. Or, alternatively, carving out categories may turn out to be less useful for some purposes than considering dimensions.

Entities:  

Mesh:

Year:  2005        PMID: 16194767     DOI: 10.1080/09540260500064959

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  20 in total

1.  Viewing the elephant from 200 feet: reconstructing the schizophrenia syndrome.

Authors:  John A Sweeney
Journal:  Schizophr Res       Date:  2011-02-01       Impact factor: 4.939

2.  Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages.

Authors:  Nick Craddock; Michael J Owen
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

3.  Psychosocial functioning, familiality, and psychiatric comorbidity in bipolar youth with and without psychotic features.

Authors:  Liwei L Hua; Timothy E Wilens; MaryKate Martelon; Patricia Wong; Janet Wozniak; Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2011-03       Impact factor: 4.384

4.  Will the Kraepelinian dichotomy survive DSM-V?

Authors:  Bernard A Fischer; William T Carpenter
Journal:  Neuropsychopharmacology       Date:  2009-03-18       Impact factor: 7.853

5.  Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder.

Authors:  Daniel H Mathalon; Ralph E Hoffman; Todd D Watson; Ryan M Miller; Brian J Roach; Judith M Ford
Journal:  Front Hum Neurosci       Date:  2010-01-29       Impact factor: 3.169

6.  Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.

Authors:  Matthew J Smith; Deanna M Barch; John G Csernansky
Journal:  Schizophr Res       Date:  2008-09-10       Impact factor: 4.939

Review 7.  Toward defining schizophrenia as a more useful clinical concept.

Authors:  Jess G Fiedorowicz; Eric A Epping; Michael Flaum
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

8.  Does diagnostic classification of early-onset psychosis change over follow-up?

Authors:  David Fraguas; María J de Castro; Oscar Medina; Mara Parellada; Dolores Moreno; Montserrat Graell; Jessica Merchán-Naranjo; Celso Arango
Journal:  Child Psychiatry Hum Dev       Date:  2007-07-31

9.  Time-lapse mapping of cortical changes in schizophrenia with different treatments.

Authors:  Paul M Thompson; George Bartzokis; Kiralee M Hayashi; Andrea D Klunder; Po H Lu; Nancy Edwards; Michael S Hong; Michael Yu; Jennifer A Geaga; Arthur W Toga; Cecil Charles; Diana O Perkins; Joseph McEvoy; Robert M Hamer; Mauricio Tohen; Gary D Tollefson; Jeffrey A Lieberman
Journal:  Cereb Cortex       Date:  2008-10-08       Impact factor: 5.357

Review 10.  Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

Authors:  O D Howes; A Egerton; V Allan; P McGuire; P Stokes; S Kapur
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.